Robert E Lambiase, MD | |
20 Catamore Blvd, East Providence, RI 02914-1204 | |
(401) 432-2520 | |
(401) 432-2457 |
Full Name | Robert E Lambiase |
---|---|
Gender | Male |
Speciality | Radiology - Diagnostic Radiology |
Location | 20 Catamore Blvd, East Providence, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124017066 | NPI | - | NPPES |
0000000D1988 | Other | NHPRI | |
7000609 | Other | RI MEDICAL ASSISTANCE | |
007056 | Other | TUFTS | |
3205036 | Other | HEALTHYSTART | |
7056 | Other | FEP BLUE CROSS | |
1600203 | Other | UNITED HEALTHPLANS | |
240172 | Other | RIHPILGRIM | |
240172 | Other | W & I PILGRIM | |
3205036 | Other | MASS MEDICAID | |
004371 | Other | BLUE CHIP | |
007056 | Other | BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 7056 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robert E Lambiase, MD 20 Catamore Blvd, East Providence, RI 02914-1204 Ph: (401) 432-2520 | Robert E Lambiase, MD 20 Catamore Blvd, East Providence, RI 02914-1204 Ph: (401) 432-2520 |
News Archive
New health care cost projections released Tuesday by the Centers for Medicare & Medicaid Services indicate that the nation's health care spending will keep outpacing economic growth despite a recent slowdown.
Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).
Today, the U.S. Food and Drug Administration authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis (WOPN), a potentially deadly condition which can occur several weeks after an episode of severe acute pancreatitis, often requiring tissue removal.
In tumor immunotherapy, the body's own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used.
› Verified 3 days ago
Gregory Iafrate, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 20 Catamore Blvd, East Providence, RI 02914 Phone: 401-432-2520 Fax: 401-432-2457 | |
Dr. Gary R Marecek, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 20 Catamore Blvd, East Providence, RI 02914 Phone: 401-432-2500 | |
Sanford L Schatz, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 20 Catamore Blvd, Rhode Island Medical Imaging, East Providence, RI 02914 Phone: 401-432-2520 Fax: 401-432-2457 | |
Robert Lewis Stickle, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 20 Catamore Blvd, East Providence, RI 02914 Phone: 401-432-2520 Fax: 401-432-2457 | |
Robert Villani, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 20 Catamore Blvd, East Providence, RI 02914 Phone: 401-432-2520 Fax: 401-432-2457 | |
Joan L Lasser, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 20 Catamore Blvd, Rhode Island Medical Imaging, East Providence, RI 02914 Phone: 401-432-2520 Fax: 401-432-2457 |